Literature DB >> 16511095

Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8.

Michael Douglas Lane1, Hyun Joo Nam, Eric Padron, Brittney Gurda-Whitaker, Eric Kohlbrenner, George Aslanidi, Barry Byrne, Robert McKenna, Nicholas Muzyczka, Sergei Zolotukhin, Mavis Agbandje-McKenna.   

Abstract

Adeno-associated viruses (AAVs) are actively being developed for clinical gene-therapy applications and the efficiencies of the vectors could be significantly improved by a detailed understanding of their viral capsid structures and the structural determinants of their tissue-transduction interactions. AAV8 is approximately 80% identical to the more widely studied AAV2, but its liver-transduction efficiency is significantly greater than that of AAV2 and other serotypes. The production, purification, crystallization and preliminary X-ray crystallographic analysis of AAV8 viral capsids are reported. The crystals diffract X-rays to 3.0 A resolution using synchrotron radiation and belong to the hexagonal space group P6(3)22, with unit-cell parameters a = 257.5, c = 443.5 A. The unit cell contains two viral particles, with ten capsid viral protein monomers per crystallographic asymmetric unit.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16511095      PMCID: PMC1952340          DOI: 10.1107/S1744309105014132

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  15 in total

1.  Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield.

Authors:  S Zolotukhin; B J Byrne; E Mason; I Zolotukhin; M Potter; K Chesnut; C Summerford; R J Samulski; N Muzyczka
Journal:  Gene Ther       Date:  1999-06       Impact factor: 5.250

2.  Adeno-associated viruses undergo substantial evolution in primates during natural infections.

Authors:  Guangping Gao; Mauricio R Alvira; Suryanarayan Somanathan; You Lu; Luk H Vandenberghe; John J Rux; Roberto Calcedo; Julio Sanmiguel; Zahra Abbas; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

3.  The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Authors:  Qing Xie; Weishu Bu; Smita Bhatia; Joan Hare; Thayumanasamy Somasundaram; Arezki Azzi; Michael S Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

4.  Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.

Authors:  N Kaludov; K E Brown; R W Walters; J Zabner; J A Chiorini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer.

Authors:  R W Walters; S M Yi; S Keshavjee; K E Brown; M J Welsh; J A Chiorini; J Zabner
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

7.  Insect cells as a factory to produce adeno-associated virus type 2 vectors.

Authors:  Masashi Urabe; Chuantian Ding; Robert M Kotin
Journal:  Hum Gene Ther       Date:  2002-11-01       Impact factor: 5.695

8.  Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.

Authors:  Seiichiro Mori; Lina Wang; Takamasa Takeuchi; Tadahito Kanda
Journal:  Virology       Date:  2004-12-20       Impact factor: 3.616

9.  Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system.

Authors:  Corinna Burger; Oleg S Gorbatyuk; Margaret J Velardo; Carmen S Peden; Philip Williams; Sergei Zolotukhin; Paul J Reier; Ronald J Mandel; Nicholas Muzyczka
Journal:  Mol Ther       Date:  2004-08       Impact factor: 11.454

10.  Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.

Authors:  Guang-Ping Gao; Mauricio R Alvira; Lili Wang; Roberto Calcedo; Julie Johnston; James M Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

View more
  14 in total

Review 1.  Adeno-associated Virus as a Mammalian DNA Vector.

Authors:  Max Salganik; Matthew L Hirsch; Richard Jude Samulski
Journal:  Microbiol Spectr       Date:  2015-08

2.  Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7.

Authors:  Odayme Quesada; Brittney Gurda; Lakshmanan Govindasamy; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Sergei Zolotukhin; Nicholas Muzyczka; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-30

3.  Structure of adeno-associated virus serotype 8, a gene therapy vector.

Authors:  Hyun-Joo Nam; Michael Douglas Lane; Eric Padron; Brittney Gurda; Robert McKenna; Erik Kohlbrenner; George Aslanidi; Barry Byrne; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

4.  Mapping a neutralizing epitope onto the capsid of adeno-associated virus serotype 8.

Authors:  Brittney L Gurda; Christina Raupp; Ruth Popa-Wagner; Matthias Naumer; Norman H Olson; Robert Ng; Robert McKenna; Timothy S Baker; Jürgen A Kleinschmidt; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

5.  Structural studies of adeno-associated virus serotype 8 capsid transitions associated with endosomal trafficking.

Authors:  Hyun-Joo Nam; Brittney L Gurda; Robert McKenna; Mark Potter; Barry Byrne; Maxim Salganik; Nicholas Muzyczka; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2011-09-07       Impact factor: 5.103

6.  Evidence for pH-dependent protease activity in the adeno-associated virus capsid.

Authors:  Maxim Salganik; Balasubramanian Venkatakrishnan; Antonette Bennett; Bridget Lins; Joseph Yarbrough; Nicholas Muzyczka; Mavis Agbandje-McKenna; Robert McKenna
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

7.  Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5.

Authors:  Michael DiMattia; Lakshmanan Govindasamy; Hazel C Levy; Brittney Gurda-Whitaker; Amy Kalina; Erik Kohlbrenner; John A Chiorini; Robert McKenna; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-09-30

Review 8.  Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Authors:  Michael E Nance; Dongsheng Duan
Journal:  Hum Gene Ther       Date:  2015-10-15       Impact factor: 5.695

9.  Comparative analysis of adeno-associated virus capsid stability and dynamics.

Authors:  Vamseedhar Rayaprolu; Shannon Kruse; Ravi Kant; Balasubramanian Venkatakrishnan; Navid Movahed; Dewey Brooke; Bridget Lins; Antonette Bennett; Timothy Potter; Robert McKenna; Mavis Agbandje-McKenna; Brian Bothner
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

10.  Generation and characterization of anti-Adeno-associated virus serotype 8 (AAV8) and anti-AAV9 monoclonal antibodies.

Authors:  Yu-Shan Tseng; Kim Van Vliet; Lavanya Rao; Robert McKenna; Barry J Byrne; Aravind Asokan; Mavis Agbandje-McKenna
Journal:  J Virol Methods       Date:  2016-07-14       Impact factor: 2.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.